p16INK4a Peptide mimetics identified via virtual screening

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 1, 2010, Pages 403-405

  Klein, Mark A ^a,b   Mayo, Kevin H ^c   Kratzke, Robert A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cyclin dependent kinase; Nuclear magnetic resonance; Peptide; Peptide mimetic; Virtual screening

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ARTICLE; DRUG SCREENING; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; NUCLEAR MAGNETIC RESONANCE; PHARMACOPHORE;

AMINO ACID SEQUENCE; BINDING SITES; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DRUG DESIGN; G1 PHASE; MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; S PHASE; THERMODYNAMICS;

EID: 72049094514     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2009.10.046     Document Type: Article

References (23)

1. Liggett Jr. W.H., and Sidransky D. J. Clin. Oncol. 16 (1998) 1197
2. Sausville E.A., Elsayed Y., Monga M., and Kim G. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 199
3. Swanton C. Lancet Oncol. 5 (2004) 27
4. Benson C., Kaye S., Workman P., Garrett M., Walton M., et al. Br. J. Cancer 92 (2005) 7
5. Craig C., Kim M., Ohri E., Wersto R., Katayose D., et al. Oncogene 16 (1998) 265
6. Lee J.H., Lee C.T., Yoo C.G., Hong Y.K., Kim C.M., et al. Anticancer Res. 18 (1998) 3257
7. Frizelle S.P., Rubins J.B., Zhou J.X., Curiel D.T., and Kratzke R.A. Cancer Gene Ther. 7 (2000) 1421
8. Fahraeus R., Paramio J.M., Ball K.L., Lain S., and Lane D.P. Curr. Biol. 6 (1996) 84
9. Frizelle S.P., Kratzke M.G., Carreon R.R., Engel S.C., Youngquist L., et al. Anticancer Res. 28 (2008) 1
10. Fahraeus R., Lain S., Ball K.L., and Lane D.P. Oncogene 16 (1998) 587
11. Piotto M., Saudek V., and Sklenar V. J. Biomol. NMR 2 (1992) 661
12. Bax A., and Davis D.G. J. Magn. Reson. 65 (1985) 355
13. Wider G., Macura S., Kumar A., Ernst R.R., and Wüthrich K. J. Magn. Reson. 56 (1984) 207
14. Wüthrich K. NMR of Proteins and Nucleic Acids (1986), Wiley-Interscience, New York
15. Jorgensen W.L., and Duffy E.M. Bioorg. Med. Chem. Lett. 10 (2000) 1155
16. Jorgensen W.L., and Duffy E.M. Adv. Drug Deliv. Rev. 54 (2002) 355
17. Lipinski C.A., Lombardo F., Dominy B.W., and Feeney P.J. Adv. Drug Deliv. Rev. 23 (1997) 3
18. Halgren T.A., Murphy R.B., Friesner R.A., Beard H.S., Frye L.L., et al. J. Med. Chem. 47 (2004) 1750
19. Friesner R.A., Banks J.L., Murphy R.B., Halgren T.A., Klicic J.J., et al. J. Med. Chem. 47 (2004) 1739
20. Glide; Schrodinger, LLC: New York.
21. Orsini M.J., Klein M.A., Beavers M.P., Connolly P.J., Middleton S.A., et al. J. Med. Chem. 50 (2007) 462
22. Russo A.A., Tong L., Lee J.O., Jeffrey P.D., and Pavletich N.P. Nature 395 (1998) 237
23. Voigt J.H., Bienfait B., Wang S., and Nicklaus M.C. J. Chem. Inf. Comput. Sci. 41 (2001) 702